LINDSEY JOHNSON: Open Payments
NPI 1558083964 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 30 payments from 15 companies in 2025. Trend: 2023 $631 · 2024 $109 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 10 | $155 |
| Sequel Med Tech, LLC | 3 | $68 |
| ABBVIE INC. | 3 | $48 |
| Mannkind Corporation | 2 | $29 |
| Radius Health, Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Abbott Laboratories | 1 | $19 |
Products named: GVOKE HYPOPEN, RECORLEV, TWIIST, QULIPTA, AFREZZA, Tymlos, JARDIANCE, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
